Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Duisburg
Clinical trial register · Germany

Clinical Trials in Duisburg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca13 Janssen Research & Development, LLC11 Eli Lilly and Company6 Octapharma4 Merck Sharp & Dohme LLC3
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Duisburg

65 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Eli Lilly and Company
Phase 3
1,000
Duisburg, Hamburg, Münster, Offenbach, Oldenburg
2026-11
Recruiting
AstraZeneca
Phase 3
1,330
Bergisch Gladbach, Berlin, Bonn, Cologne, Dresden, Duisburg, Essen, Frankfurt am Main
2026-09-15
Recruiting
AstraZeneca
Phase 3
915
Bochum, Bonn, Dresden, Duisburg, Frankfurt am Main, Hamburg, Hanover, Herne
2026-07-16
Recruiting
AstraZeneca
Phase 3
600
Amberg, Bad Oeynhausen, Berlin, Bochum, Brandenburg an der Havel, Daaden, Duisburg, Eisenach
2026-07-08
Recruiting
AstraZeneca
Phase 3
1,200
Bad Oeynhausen, Berlin, Chemnitz, Damme, Duisburg, Elsterwerda, Erlangen, Essen
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Berlin, Cologne, Damme, Deggingen, Duisburg, Essen, Falkensee, Frankfurt
2026-07-06
Recruiting
AstraZeneca
Phase 3
900
Bad Oeynhausen, Berlin, Brandenburg an der Havel, Chemnitz, Duisburg, Erlangen, Frankfurt, Hamburg
2026-07-06
Recruiting
Octapharma
Phase 4
28
Bonn, Duisburg, Hamburg
2026-04
Recruiting
Timo Munz
Observational
543
Amberg, Berlin, Chemnitz, Dresden, Duisburg, Freiburg im Breisgau, Hamburg, Kassel
2026-03-02
Recruiting
Eli Lilly and Company
Phase 3
900
Bochum, Bünde, Duisburg, Hamburg, Karlsruhe, Leipzig, München, Offenbach
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
1,980
Cologne, Dresden, Duisburg, Essen, Hamburg, Leipzig, Lingen, Mainz
2026-02-06
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Dresden, Duisburg, Essen, Hamburg, München, Nürtingen
2025-12-19
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bad Saarow, Bielefeld, Bonn, Cologne, Dresden, Duisburg, Düsseldorf, Erlangen
2025-12-12
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Braunschweig, Duisburg, Düsseldorf, Essen, Frankfurt am Main, Hamburg, Heidelberg, München
2025-09-02
Active, closed
Novo Nordisk A/S
Observational
245
Pirna, Bramsche, Bünde, Dortmund, Duisburg, Fulda, Herne, Hof
2025-08-28
Recruiting
AstraZeneca
Phase 3
700
Augsburg, Berlin, Braunschweig, Cologne, Dresden, Duisburg, Düsseldorf, Essen
2025-08-06
Recruiting
Hoffmann-La Roche
Phase 3
75
Bonn, Duisburg, Frankfurt/M.
2025-06-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Nürtingen, Stuttgart, Munich, Nuremberg, Potsdam, Frankfurt am Main, Cologne, Duisburg
2025-05-13
Active, closed
Hoffmann-La Roche
Observational
44
Bonn, Duisburg, Frankfurt/M.
2025-04-29
Active, closed
Sanofi
Phase 2
204
Berlin, Duisburg, Frankfurt, Hanover, Tübingen, Ulm
2025-03-28
Active, closed
Eli Lilly and Company
Phase 2
143
Augsburg, Berlin, Brandenburg an der Havel, Duisburg, Frankfurt am Main, Halle, Hamburg, Hanover
2024-10-10
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Berlin, Dachau, Duisburg, Frankfurt am Main, Halle, Heidelberg, Kiel, Leipzig
2024-07-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Pforzheim, München, Ulm, Hanover, Lüneburg, Rostock, Cologne, Duisburg
2024-06-05
Active, closed
AstraZeneca
Observational
111
Aschaffenburg, Augsburg, Bergisch Gladbach, Berlin, Bonn, Cologne, Dresden, Duisburg
2024-02-14
Active, closed
AnaptysBio, Inc.
Phase 2
132
Berlin, Brandenburg, Dachau, Duisburg, Erlangen, Hamburg, Kiel, Ulm
2023-12-04
Recruiting
Octapharma
Phase 4
28
Berlin, Duisburg, Hamburg
2023-11-28
Active, closed
AstraZeneca
Phase 3
1,898
Bergisch Gladbach, Berlin, Braunschweig, Cologne, Dresden, Duisburg, Frankfurt, Frankfurt am Main
2023-11-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Ulm, Dachau, Munich, Frankfurt am Main, Hanover, Lüneburg, Duisburg, Minden
2023-10-25
Active, closed
Jena University Hospital
Phase 3
250
Heidelberg, Wetzlar, Hanover, Planegg, Duisburg, Paderborn, Würselen, Halle
2023-05-16
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Bad Krozingen, Bad Oeynhausen, Berlin, Duisburg, Düsseldorf, Erlangen, Essen, Frankfurt
2023-04-17
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Cologne, Duisburg, Erlangen, Essen, Frankfurt am Main, Freiburg im Breisgau, Markkleeberg, Mettmann
2023-03-23
Recruiting
Acandis GmbH
Observational
153
Aschaffenburg, Augsburg, Bonn, Bremerhaven, Dresden, Duisburg, Erfurt, Halle
2023-01-25
Recruiting
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
NCT06932081Adult Congenital Heart Disease, Congenital Heart Disease, Systemic Right Ventricle, Transposition of the Great Arteries
Leiden University Medical Center
Observational
400
Duisburg
2023-01-01
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Duisburg, Düsseldorf, Leipzig, Dresden, Hamburg, Mutlangen
2022-12-14
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Dachau, Duisburg, Hanover, Jerichow, Lüneburg
2022-09-13
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Berlin, Cologne, Dachau, Dresden, Duisburg, Erlangen, Essen, Frankfurt
2022-07-22
Recruiting
Octapharma
Phase 3
38
Berlin, Bonn, Duisburg
2022-07-01
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Dresden, Duisburg, Hamburg, Hanover, München, Tübingen
2022-05-23
Active, closed
Eli Lilly and Company
Phase 3
925
Freiburg im Breisgau, Heidelberg, Nürtingen, Ulm, Tübingen, Munich, Frankfurt am Main, Duisburg
2022-04-14
Active, closed
Janssen Research & Development, LLC
Phase 1/2
235
Dresden, Duisburg, Frankfurt am Main, Herne, Mettmann, Münster, Ulm
2022-04-11
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Berlin, Braunschweig, Cologne, Dachau, Duisburg, Halle, Hanover, Jerichow
2022-01-19
Active, closed
MedSIR
Phase 2
393
Cologne, Duisburg, Essen, Manheim, Potsdam
2021-08-05
Active, closed
Pfizer
Phase 3
599
Göttingen, Wesel, Jena, Berlin, Duisburg, Frankfurt, Heidelberg, Leipzig
2021-05-12
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
NCT04752722Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
DrugPhase 2
enGene, Inc.
Phase 1/2
350
Cologne, Duisburg, Erlangen, Mettmann, Nürtingen, Tübingen
2021-04-22
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Cologne, Duisburg, Herne, Markkleeberg, Mettmann, Münster, Nuremberg, Nürtingen
2020-12-18
Active, closed
Universität Münster
Phase 2
190
Münster, Augsburg, Bergisch Gladbach, Cologne, Duisburg, Düsseldorf, Essen, Frankfurt
2020-12-10
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Augsburg, Braunschweig, Dresden, Duisburg, Düesseldorf, Essen, Frankfurt am Main, Hanover
2020-12-07
Recruiting
Evaluate the Continued Safety and Performance of the Foot and Ankle Products
NCT04715139Hyperpronated Foot, Reconstruction Surgeries of the Foot, Fixation of Fractures and Fusion (Bunionectomy Osteotomies) of the Foot/Ankle, Fixation of Small Bone Fragments of the Foot/Ankle
Arthrex, Inc.
Observational
700
Duisburg
2020-12-01
Active, closed
Exelixis
Phase 3
575
Nürtingen, Duisburg, Gütersloh, Münster, Lübeck, Berlin, Hamburg, Hanover
2020-10-19
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Braunschweig, Cologne, Dresden, Duisburg, Hanover, München, Münster, Nürtingen
2020-09-23
Active, closed
University Hospital, Basel, Switzerland
Not applicable
382
Duisburg, Essen, Heidelberg, Wuppertal
2020-07-28
Active, closed
AstraZeneca
Phase 3
1,012
Berlin, Duisburg, Hamburg, Herne, Mettmann, Münster, Nuremberg, Nürtingen
2020-07-13
Active, closed
Pfizer
Phase 3
1,068
Duisburg, Frankfurt, Münster, Nürtingen, Tübingen
2019-12-30
Active, closed
RhoVac APS
Phase 2
180
Dresden, Duisburg, Hagenow, Halle, Nürtingen, Tübingen
2019-11-19
Recruiting
Abbott Medical Devices
Observational
2,000
Tübingen, Ingolstadt, Cologne, Duisburg, Düsseldorf, Mönchengladbach, Lübeck, Gera
2019-03-13
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Braunschweig, Duisburg, Homburg, Magdeburg, Münster, Nürtingen
2019-01-25
Active, closed
Celgene
Phase 3
363
Baden-Warttemberg, Berlin, Cologne, Dresden, Duisburg, Düsseldorf, Hamburg, Keil
2019-01-02
Active, closed
AstraZeneca
Phase 3
895
Bergisch Gladbach, Bremen, Cologne, Duisburg, Freiburg im Breisgau, Heinsberg, Mettmann, Nuremberg
2018-10-31
Active, closed
Gilead Sciences
Phase 2
502
Duisburg, Frankfurt, Freiburg im Breisgau, Hamburg, Heidelberg, Herne, Jena, Koblenz
2018-08-13
Active, closed
AstraZeneca
Phase 3
1,018
Berlin, Cologne, Duisburg, Hanover, Heidelberg, Marburg, Mettmann, Mühlheim An Der Ruhr
2018-05-14
Active, closed
Heinrich-Heine University, Duesseldorf
Phase 2
136
Bochum, Duisburg, Düsseldorf, Lünen, Münster, Krefeld
2018-03-06
Recruiting
Octapharma
Observational
200
Berlin, Bonn, Duisburg, Essen, Frankfurt
2018-02-13
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Duisburg, Düsseldorf, Erlangen, Giessen, Göttingen, Jena, Leipzig, Oeynhausen
2018-01-07
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Nürtingen, Waldshut-Tiengen, Mannheim, Duisburg, Bonn, Hamburg
2016-12-22
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Aachen, Bergisch Gladbach, Berlin, Braunschweig, Cologne, Duisburg, Emmendingen, Frankfurt am Main
2013-10-14
Rows per page Showing 1–65 of 65
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/duisburg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 65 of those studies with a site in Duisburg.

How many clinical trials are recruiting in Duisburg?

28 of the 65 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 36 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Duisburg), 65 studies
PhaseStudiesRecruitingShare
Phase 3351653.8%
Phase 212118.5%
Observational10615.4%
Not applicable324.6%
Phase 1/2213.1%
Phase 4223.1%
Phase 2/3101.5%

Most active sponsors

Lead sponsors with the most studies (Duisburg)
Lead sponsorStudiesRecruiting
AstraZeneca137
Janssen Research & Development, LLC112
Eli Lilly and Company63
Octapharma44
Merck Sharp & Dohme LLC32
Hoffmann-La Roche21
Pfizer20
Weill Medical College of Cornell University22
Abbott Medical Devices11
Acandis GmbH11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.